These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7690342)

  • 1. The Mycobacterium bovis BCG 64-kDa surface protein is antigenically shared with different mouse tumor cells and has anti-tumor activity in immunized mice.
    Ahsan CR; Sasaki J
    Immunol Lett; 1993 Jun; 36(3):235-8. PubMed ID: 7690342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
    Ahsan CR; Sasaki J
    FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis between BCG and tumor cells by BCG-monoclonal antibodies.
    Sasaki J; Kitagawa M; Tamagake T; Narita S; Ahsan CR; Lu CL
    Microbiol Immunol; 1989; 33(11):951-5. PubMed ID: 2687649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of mycobacterial heat shock protein (HSP64) on Meth A tumour cells.
    Sasaki J; Dejehansart M; De Bruyn J
    Immunol Cell Biol; 1994 Oct; 72(5):415-8. PubMed ID: 7530694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
    Minden P; Sharpton TR; McClatchy JK
    J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 9. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6.
    Fan XL; Yu TH; Gao Q; Yao W
    Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):683-90. PubMed ID: 17033714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 65-kDa stress protein: is it related to the tumor specific antigen?
    Ahsan CR; Sasaki J; Nomaguchi H
    Immunol Lett; 1993 Mar; 35(3):291-2. PubMed ID: 7685737
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center.
    Zbar B; Minden P; McClatchy JK; Rapp HJ
    J Natl Cancer Inst; 1976 Feb; 56(2):443-4. PubMed ID: 176390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumor resistance with BCG-associated tumor antigen.
    Crum ED; McGregor DD
    Int J Cancer; 1977 Nov; 20(5):805-12. PubMed ID: 200576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice.
    Tollefsen S; Pollock JM; Lea T; Harboe M; Wiker HG
    Scand J Immunol; 2003 Feb; 57(2):151-61. PubMed ID: 12588661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective anti-tumor immunity induced in mice by a two-step vaccination protocol.
    Martino A; Vismara D; Cicconi R; Delpino A; Ivanyi J; Colizzi V; Cassol M; Fraziano M; Piselli P
    In Vivo; 2001; 15(5):425-8. PubMed ID: 11695241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of sarcoma 180 in normal and splenectomized BALB/c mice immunized with BCG.
    Rumi LS; García MS; Barañao RI; Schwint AE
    Acta Physiol Lat Am; 1982; 32(2):123-30. PubMed ID: 6763450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of microscopic hepatic metastases by active specific immunization.
    Sukumar S; Hunter JT; Terata N; Rapp HJ
    Cancer Immunol Immunother; 1983; 14(3):151-4. PubMed ID: 6340824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity in sensitized guinea pigs of MPB 70, a protein specific for some strains of Mycobacterium bovis BCG.
    Hasløv K; Andersen AB; Bentzon MW
    Scand J Immunol; 1987 Oct; 26(4):445-54. PubMed ID: 3317787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.
    Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ
    Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.